Researchers find new role for cannabinoids in vision

A multidisciplinary team including researchers from the Montreal Neurological Institute has improved our understanding of how cannabinoids, the active agent in marijuana, affect vision in vertebrates. Learn more.

Help us improve!

Please complete this brief feedback survey and let us know what is on your mind!

A Brilliant Night: Save the Date

This year, the second annual A Brilliant Night cocktail dinatoire will be held at Windsor Station to raise money for brain tumour research. Through interactive, immersive technology, guests will be inspired and educated in a sensorial and moving environment. Learn more


Gaming camera could aid MS treatment

A Neuro physiatrist worked with a McGill engineering researcher to develop a portable and economical way to assess walking difficulties in MS patients. Learn more.

Continuing the fight against ALS

The Neuro offers excellent care to ALS patients, and Neuro researchers continue the fight to develop better treatments for the disease. Learn about some experimental therapies and one family's struggle with ALS in this Montreal Gazette article.

A cyclotron is a particle accelerator indispensable for PET imaging and opperates under guidelines set out by the Canadian Nuclear Safety Commission (CNSC). As per CNSC regulations, we are informing the public that The Neuro is equipped with a cyclotron facility Learn More

A valuable second opinion

Taking his wife's advice, Michel Desmarteaux sought a second opinion on what was considered an inoperable brain tumour, bringing him to the care of MNI neurosurgeon Kevin Petrecca. Learn what happens next in this report from TVA Nouvelles (en français)

Big Data Science

Scientists at the Montreal Neurological Institute and Hospital have used a powerful tool to better understand the progression of late-onset Alzheimer’s disease (LOAD), identifying its first physiological signs. Learn more.

Researchers open new path of discovery in Parkinson’s disease

A team of scientists from University of Montreal and the Neuro have discovered that two genes associated with Parkinson's disease (PD) are key regulators of the immune system, providing direct evidence linking Parkinson's to autoimmune disease. Learn More

$4M boost for intellectual disabilities research

The Sandra and Alain Bouchard Foundation has given a $4-million boost to scientists at the Montreal Neurological Institute and Hospital, establishing The Sandra and Alain Bouchard Intellectual Disability Research Program. Learn More.

Seeing what the eyes are telling us

The eyes are nothing without the brain. While the eyes capture the photons reflecting off our surrounding environment, it’s the brain’s job to turn that information into something meaningful, something that helps us survive and prosper. Learn more.

Big Data Provides New Tools

A new partnership with EMC Corporation will bring greater computing capacity to the McGill community. Among those benefiting will be the brain-mapping project of Alan Evans’ lab at the MNI, as well as many others. Learn more.

The Neuro is brain research, patient care and training

The Montreal Neurological Institute and Hospital – The Neuro, is a world-leading destination for brain research and advanced patient care. Since its founding in 1934 by renowned neurosurgeon Dr. Wilder Penfield, The Neuro has grown to be the largest specialized neuroscience research and clinical centre in Canada, and one of the largest in the world. The seamless integration of research, patient care, and training of the world’s top minds make The Neuro uniquely positioned to have a significant impact on the understanding and treatment of nervous system disorders.